Advertisement

Ranbaxy's merger News

alt
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.  






Loading...
english news
NEWS ON ONE CLICK